JMI Syringe posts 234% growth in profit in nine months of FY25
JMI Syringes & Medical Devices reported a 234% growth in its net profit during the first nine months of FY2024-25, driven by increased sales and product price hikes.
According to its quarterly report for nine months, its net profit soared to Tk5.05 crore with an earnings per share of Tk1.68, a significant growth from Tk1.51 crore and EPS Tk0.50 in the nine months of the previous fiscal year.
Regarding its profit growth, the company said that during the reported period, revenue and net profit increased due to an increase in sales and an increase in sales price of its products, as well as a reduction in expenses.
Keep updated, follow The Business Standard's Google news channel
At the end of 31 March, its net asset value increased to Tk262 crore, up from Tk260 crore at the end of June 2024, its price-sensitive information showed.
However, it incurred a loss in the third quarter during the January to March quarter with Tk7 lakh, and a loss per share Tk0.02.
At the same time in the previous year, its net profit was Tk1.07 crore with EPS of Tk0.36.
Its share price closed at Tk139 each at the Dhaka Stock Exchange (DSE) today (28 April), which is 0.86% down from the previous trading session.
In FY24, it made a profit of Tk3.88 crore with EPS Tk1.26, and it had paid a 10% cash dividend to its shareholders.
